Latest News


Research Excellence

New approach delivers breakthrough for pain researchers.

Researchers at the Kolling Institute have made important progress towards the development of new treatments for chronic pain by identifying a small group of cells which can control pain responses. The breakthrough comes as approximately 20 per cent of the world’s population suffers from chronic pain, including around 3.4 million Australians. Dr Neda Assareh, a neuroscientist research fellow from th.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Research questions the value of injectable medications for osteoarthritis.

Our researchers at the Kolling Institute are encouraging those with osteoarthritis to rely on treatments with a proven track record and avoid quick fixes without the data to show they work. The comments follow a steady rise in osteoarthritis cases nationally, with around three million Australians now living with the condition, and many forced to retire early. The rise in cases has coincided with st.....
Read more

Category: Musculoskeletal Research, Research Excellence

Researchers call for a greater focus on the physical impact of whiplash injuries .

Researchers from the Kolling Institute have led an international study investigating why some people spontaneously recover from whiplash following a motor vehicle collision, while others don’t. Their work has uncovered new evidence indicating it may relate to the health of muscles and stress. More than 140 people were recruited to the longitudinal study, which involved research teams from the Unite.....
Read more

Category: Research Excellence, World-leading technology

A simple yet smart approach to spinal cord injuries may offer a new way forward.

Researchers based at Royal North Shore Hospital have launched the first study of its kind in the world to support those with a spinal cord injury. The team from the Kolling Institute’s John Walsh Centre for Rehabilitation Research is now seeking recruits for the clinical trial which is investigating the benefits of an approach combining breathing techniques with heart rate feedback. Study lead Prof.....
Read more

Category: New Treatment, Research Excellence

World leading Meniere’s disease expert joins the Kolling.

In a sign of the growing neuroscience expertise at the Kolling Institute, internationally recognised Meniere’s disease expert Professor Jose Antonio Lopez Escamez has relocated from Spain to the institute. Professor Lopez Escamez has launched an exciting new international research program into the disease, extending his body of work in Europe. Meniere’s disease is a rare disease of the inner ear th.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

New opportunities strengthening our culture of research excellence.

In an exciting announcement, three clinical research fellows have been appointed within the Northern Sydney Local Health District (NSLHD). The positions are part of an initiative developed by the University of Sydney’s Faculty of Medicine and Health Northern Sydney (Arabanoo) Precinct and the NSLHD. The new roles will drive interdisciplinary research activity, develop research capabilities and incr.....
Read more

Category: Research Excellence

Global recognition for one of our musculoskeletal researchers.

In a sign of the international impact of our research at the Kolling Institute, a prestigious award has been presented to Professor Chris Little during the World Congress on Osteoarthritis in Denver, Colorado. More than 700 researchers and clinicians attended the event where Professor Little was presented with the 2023 Basic Science Research Award by the Osteoarthritis Research Society Internationa.....
Read more

Category: Awards, Musculoskeletal Research, Research Excellence

New approach revolutionising ovarian cancer research.

With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kolling Institute is offering hope. The disease has the lowest survival rate of any women’s cancer, with only 48 per cent of women living beyond five years after diagnosis. Ovarian cancer is often diagnosed late because the symptoms are vague, like bloating, nausea, indigestion, excessive tiredness, and.....
Read more

Category: New Treatment, Research Excellence

Recognition of our impact on the world stage.

Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than a dozen researchers from the Kolling have been profiled in an international study recognising the world’s best. Published by Stanford University, the study has identified the top two per cent of researchers in the world across individual fields. The study is based on metrics from Scopus, a database o.....
Read more

Category: Research Excellence

Philanthropic funds creating travel opportunities  .

A collection of emerging research leaders will have the chance to broaden their research experience thanks to funding provided through the Skipper Jacobs Charitable Trust. Close to $40,000 will be shared amongst five early-to-mid career researchers, allowing them to travel nationally and internationally expanding their research and developing new skills. It’s anticipated the travel program will not.....
Read more

Category: Awards, Research Excellence